42 results about "Scutellaria barbata" patented technology

The invention belongs to the technical field of biological medicines, and particularly relates to a traditional Chinese medicine composition for treating metabolism-related fatty liver diseases and a preparation method thereof. The technical problem to be solved by the invention is to provide a new choice for treating metabolism-related fatty liver diseases. According to the technical scheme, the traditional Chinese medicine composition for treating the metabolism-related fatty liver disease is prepared from the following components: radix paeoniae rubra, cyrtomium fortunei, curcuma zedoary, sculellaria barbata, herba epimedii, fingered citron, semen cassiae and herba artemisiae scopariae. The invention is mainly used for providing a new choice for treating the metabolism-related fatty liver disease, and has a wide application prospect.

The invention provides an anti-cancer medicine and food homologous composition and a preparation method thereof. The composition is prepared from the following components in parts by weight: 5 to 10 parts of lipoic acid, 30 to 50 parts of nano curcumin, 2 to 7 parts of berberine, 50 to 100 parts of beta-glucan, 15 to 35 parts of polymethylacrylic acid, 15 to 25 parts of herba hedyotidis diffusae extract, 7 to 15 parts of scutellaria barbata baicalein, 25 to 55 parts of astragalus polysaccharide, 8 to 18 parts of coix seed ester and 10 to 15 parts of cordyceps cicadae. Through a space-time targeting synergistic release mechanism of a bionic nanocellulose skeleton and in combination with pH / enzyme double-response intelligent regulation and control, three-stage precise synergistic effects of oxidation resistance, apoptosis promotion and immune activation are realized, the limitation that a traditional medicinal and edible composition is poor in targeting property, low in synergistic efficiency and uncontrollable in toxicity is broken through, and the medicinal and edible composition has a broad application prospect. High-efficiency and low-toxicity tumor multi-channel synergistic intervention is achieved in a natural component system for the first time, and the actual effect of the whole medicinal and edible composition on cancer and swelling resistance is improved.

This invention provides a traditional Chinese medicine preparation for promoting blood circulation and relieving pain, and its preparation method, relating to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from the following parts by weight of traditional Chinese medicine raw materials: 10-30 parts of Polygonatum sibiricum, 10-30 parts of Spatholobus suberectus, 10-30 parts of Curcuma longa, 5-20 parts of Sparganium stoloniferum, 5-20 parts of Areca catechu peel, 5-20 parts of Polygonum hydropiper, 5-20 parts of Rhizoma Scutellariae, 1-5 parts of Artemisia argyi, 5-20 parts of Solanum nigrum, 5-20 parts of Catechu, 10-30 parts of Scutellaria barbata, 5-20 parts of Aristolochia debilis, 10-30 parts of Astragalus membranaceus, and 5-20 parts of Artemisia argyi oil. The traditional Chinese medicine preparations described in this invention differ from those that typically enhance the efficacy of a single herb. Instead, they exhibit a synergistic relationship where one plus one equals more than two. The principal, assistant, adjuvant, and guide herbs complement each other, combining both tonifying and purging effects. This approach effectively promotes the dissipation of blood stasis, unblocks the flow of qi and blood in the meridians, eliminates local inflammation, and reduces swelling and pain. Simultaneously, it nourishes the tendons and bones, supports the body's vital energy, and enhances the body's ability to resist pathogens and repair damage. Thus, it comprehensively alleviates pain caused by various factors, achieving the goals of promoting blood circulation, removing blood stasis, clearing the meridians, reducing inflammation and swelling, and relieving pain.

The invention discloses a traditional Chinese medicine compound preparation for treating lung cancer and a classified extraction and enzyme-membrane purification preparation method thereof, and the traditional Chinese medicine compound preparation comprises the following traditional Chinese medicine raw materials: monarch drugs: sculellaria barbata, radix sophorae flavescentis, curcuma zedoary and centipede; the ministerial drug is prepared from the following raw materials: radix astragali, rhizoma polygonati and radix angelicae sinensis; the adjuvant drugs are prepared from the following raw materials: coix seeds, thunberg fritillary bulbs and stiff silkworms; and the conductant drug is prepared from the following raw materials: gallnut, red dates and liquorice. According to the traditional Chinese medicine compound preparation, a monarch and ministerial dynamic coupling model is provided, the sculellaria barbata-curcuma zedoary monarch drug targets a tumor microenvironment, the astragalus membranaceus-polygonatum kingianum ministerial drug regulates immunity in a time sequence mode, and the limitation of traditional single-target compatibility is broken through.

The invention relates to application of a traditional Chinese medicine composition in preparation of a medicine for preventing or treating myelodysplastic syndrome and related complications thereof. The traditional Chinese medicine composition comprises sculellaria barbata, astragalus membranaceus, angelica sinensis, nightshade, radix curcumae, red ginseng, duchesnea indica, saussurea involucrata, cyclea verticillata and salvia miltiorrhiza. The traditional Chinese medicine composition has a good prevention and treatment effect on myelodysplastic syndrome and related complications thereof, can effectively inhibit proliferation of hematological tumor cells, and also can inhibit proliferation of the myelodysplastic syndrome by increasing the hemoglobin level, reducing the inflammatory cytokine level and reducing the proportion of peripheral blood T cells. Anemia, inflammation and low immune function caused by the myelodysplastic syndrome can be treated. The invention provides an effective strategy for prevention or treatment of myelodysplastic syndrome and related complications thereof, and provides a new direction for application of the traditional Chinese medicine composition.

The invention relates to a KASP molecular marker associated with scutellarin of erigeron breviscapus and application of the KASP molecular marker, and belongs to the technical field of genetic engineering. The primers of the KASP molecular marker associated with the scutellarin of the erigeron breviscapus comprise a forward primer 1, a forward primer 2 and a common reverse primer; the nucleotide sequence of the forward primer 1 is as shown in SEQ ID NO. 1; the nucleotide sequence of the forward primer 2 is as shown in SEQ ID NO. 2; the nucleotide sequence of the common reverse primer is as shown in SEQ ID NO.3. By utilizing the KASP technology, the SNP site and the corresponding primer combination provided by the invention not only improve the plant variety selection efficiency, but also are beneficial to shortening the breeding cycle and accelerating the cultivation of high-quality plant varieties. The markers have good genetic stability and high resolution, are suitable for high-throughput detection, and have significant application value in the field of plant breeding.

The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating tumors and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 3 to 6 parts of traditional Chinese medicine extract, 5 to 10 parts of modified SiO2 and 8 to 12 parts of cellulose-chitosan compound, the traditional Chinese medicine extract is prepared from the following raw material components: 20 to 30 parts of herba scutellariae barbatae, 20 to 30 parts of herba hedyotidis diffusae, 15 to 25 parts of radix astragali seu hedysari, 10 to 20 parts of radix codonopsis, 10 to 15 parts of radix notoginseng and 5 to 10 parts of radix glycyrrhizae. The prepared traditional Chinese medicine composition can effectively inhibit tumor growth and has high biological safety and bioavailability.

This invention belongs to the field of gastric disease treatment, specifically relating to a traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and its preparation method. The traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia comprises the following raw materials in parts by weight: Agrimonia pilosa 10-15 parts, Cyperus rotundus 8-10 parts, Scutellaria barbata 10-15 parts, Lobelia chinensis 10-15 parts, Patrinia scabiosaefolia 13-17 parts, Scutellaria baicalensis 7-11 parts, Hedyotis diffusa 10-15 parts, Prunella vulgaris 10-15 parts, Hedyotis diffusa 5-7 parts, Perilla frutescens 8-10 parts, Coptis chinensis 5-7 parts, Angelica sinensis 5-7 parts, etc. This invention focuses on the core pathogenesis of damp-heat in the spleen and stomach and stagnation of gastric collaterals. The Chinese herbal composition has the effects of clearing heat and removing dampness, regulating qi and harmonizing the stomach, nourishing blood and unblocking collaterals. Clinically, it can significantly improve the OLGA / OLGIM stage of patients with chronic atrophic gastritis with intestinal metaplasia, with a total effective rate of 65.1%, providing a safe and effective Chinese medicine solution for precancerous lesions of the stomach.

The invention belongs to the field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for treating various difficult miscellaneous diseases, and a preparation method and application thereof. The traditional Chinese medicine composition comprises the following components in parts by weight: folium artemisiae argyi, frankincense, rhizoma acori graminei, saponin, fructus aurantii, ligusticum wallichii, cassia twig, eucommia ulmoides, scorpio, radix angelicae, asarum, rosin, realgar, radix angelicae pubescentis, loofah sponge, clove, safflower carthamus, dandelion, oldenlandia diffusa, sculellaria barbata, rose, Chinese lobelia, radix paeoniae rubra, bamboo shavings, radix clematidis, perilla leaf, radix bupleuri and rhizoma corydalis. Through compatibility and component optimization of various traditional Chinese medicinal materials, the safety, the drug effect exertion and the sustainability are remarkably improved.

This invention discloses a traditional Chinese medicine composition for treating liver fibrosis with damp-heat toxicity, comprising the following raw materials in parts by weight: 20-30 parts of processed turtle shell, 18-25 parts of Oldenlandia diffusa, 11-15 parts of Curcuma zedoaria, 20-30 parts of processed Salvia miltiorrhiza (wine-processed), 14-20 parts of Scutellaria barbata, 11-15 parts of Epimedium, 10-15 parts of Artemisia capillaris, 14-20 parts of Sedum sarmentosum, 7-10 parts of Bupleurum chinense, 7-10 parts of Curcuma longa, 6-8 parts of dried ginger, 11-15 parts of stir-fried Atractylodes macrocephala, 18-25 parts of Astragalus membranaceus, 7-10 parts of Prunus persica, 8-12 parts of Schisandra chinensis, 4-6 parts of Panax notoginseng (powder), 14-20 parts of Poria cocos, and 3-5 parts of Cinnamomum cassia. This traditional Chinese medicine composition is developed based on the principles of TCM syndrome differentiation and treatment for liver fibrosis with damp-heat toxicity, and has the expected therapeutic effect on this condition.

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine for treating lung cancer and a preparation method and application thereof. The traditional Chinese medicine is prepared from the following raw materials in parts by weight through water extraction or decoction: 3-4 parts of wild buckwheat rhizome, 2-3 parts of sculellaria barbata, 2-3 parts of oldenlandia diffusa and 0.5-2 parts of pericarpium citri reticulatae. According to the traditional Chinese medicine formula, through the synergistic effect of compatibility of the raw materials, the treatment effect of the traditional Chinese medicine can be brought into play, after water extraction or decoction, the traditional Chinese medicine has the remarkable inhibition effect on lung cancer cells or lung cancer no matter at the cellular level or in the animal body, and the traditional Chinese medicine is simple in compatibility and low in cost, has the advantage of treating both symptoms and root causes of the lung cancer and has a wide application prospect. Good clinical values are realized.

The invention discloses a traditional Chinese medicine formula for adjuvant therapy of esophageal cancer and radiation esophagitis and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine, the traditional Chinese medicine formula comprises the following raw materials: sculellaria barbata, hedyotis diffusa, nightshade, reed root, salvia chinensis, concha arcae, radix glehniae, radix actinidiae chinensis, cynanchum paniculatum, lotus leaf, blackberry lily, subprostrate sophora, rabdosia rubescens, scaphium scaphigerum, amomum cardamomum, fructus forsythiae, selfheal and garden balsam. , radix clematidis, radix scrophulariae, salvia miltiorrhiza and oyster. The formula has the effects of clearing away heat and toxic materials, diminishing swelling and removing stasis, nourishing yin and moistening dryness, and activating meridians to stop pain, can effectively relieve choking of esophageal cancer patients and red, swollen and painful throat of radiation esophagitis patients in the radiotherapy period, and improves the life quality and treatment effect of the patients.

This invention relates to a traditional Chinese medicine composition for treating primary liver cancer. The composition is made from the following raw materials in parts by weight: 25-30 parts of *Codonopsis pilosula*, 10-15 parts of *Cremastra appendiculata*, 15-20 parts of *Scutellaria barbata*, 20-25 parts of *Curcuma zedoaria*, 10-15 parts of *Polygonum cuspidatum*, and 5-10 parts of *Citrus reticulata*. This invention also provides applications of the traditional Chinese medicine composition. The "Liver-Clearing Formula" of this invention uses a combination of various traditional Chinese herbs, focusing on "damp-heat, phlegm, qi stagnation, and blood stasis." The six herbs are combined to both attack and tonify, supporting the body's resistance and eliminating pathogenic factors, aiming to achieve the goal of strengthening the body's resistance and reducing pathogenic factors, thus achieving the effects of clearing heat and dampness, promoting qi circulation, resolving phlegm, and breaking up blood stasis. This helps improve the patient's quality of life and prognosis. At the same time, the use of this traditional Chinese medicine is expected to reduce the toxicity and enhance the efficacy of Western medicine, reducing adverse reactions and achieving the best therapeutic effect.

The invention discloses traditional Chinese medicine granules for treating lung cancer and a preparation method thereof, and relates to the technical field of traditional Chinese medicine formulas. The invention discloses traditional Chinese medicine granules for treating lung cancer. The traditional Chinese medicine composition is prepared from aged black nightshade, marsdenia tenacissima, podophyllum, thunberg fritillary bulb, sculellaria barbata, oldenlandia diffusa, ganoderma applanatum, poria cocos, phellinus igniarius, honeysuckle, fructus forsythiae, dandelion, carbonized sanguisorba root, humifuse euphorbia herb, phyllanthus urinaria, folium isatidis, astragalus membranaceus, cottonrose hibiscus leaves, pericarpium trichosanthis, lance asiabell root, radix ranunculi ternati, spicate clerodendranthus herb, platycodon grandiflorum, aster, rhizoma atractylodis macrocephalae, herba cepbalanoplosis segeti, scorpio, turtle shell, radix ophiopogonis, codonopsis pilosula, radix pseudostellariae, momordica grosvenori, fig, Japanese ardisia herb and pyrrosia lingua. The traditional Chinese medicine has the effects of detoxifying, astringing to stop bleeding, astringing lung and improving symptoms, can finally reduce relapse, and is safe and reliable.

This invention belongs to the field of biopharmaceuticals and specifically discloses the preparation and application of a compound formulation of Hedyotis diffusa (5-30 parts), Scutellaria barbata (3-10 parts), Houttuynia cordata (3-6 parts), Ganoderma lucidum (2-4 parts), and astaxanthin for adjuvant tumor treatment. This compound is prepared by gradient decoction, nanoemulsification, and synergistic combination of ingredients, including Hedyotis diffusa (5-30 parts), Scutellaria barbata (3-10 parts), Houttuynia cordata (3-6 parts), Ganoderma lucidum (2-4 parts), and astaxanthin (0.5-1 parts). The combination of gradient temperature-controlled decoction and nanoemulsification (particle size 50-200 nm) significantly improves the bioavailability of heat-sensitive components (such as astaxanthin), allowing for the design of various dosage forms (tablets, capsules, and pills) to meet diverse clinical needs. Animal models have demonstrated that this compound enhances the efficacy of cytarabine and cisplatin while reducing chemotherapy toxicity (resumption of ALT / AST levels to normal). This invention combines multi-target anti-tumor and immunomodulatory properties with dosage form stability, providing an innovative solution for adjuvant tumor treatment.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition for treating tinnitus. Its ingredients include: vinegar-processed turtle shell, stir-fried jujube seed, anemarrhena rhizome, phellodendron bark, rehmannia root, white peony root, poria cocos, fleeceflower root vine, scutellaria barbata, oldenlandia diffusa, stir-fried atractylodes macrocephala, prunella vulgaris, and cicada slough. The TCM composition of this invention exhibits significant multi-dimensional beneficial effects in treating tinnitus. Compared with Western medicine treatments, it avoids the side effects such as low blood pressure, dizziness, drowsiness, and dry mouth associated with vasodilators and antidepressants, and overcomes the drawbacks of physical therapy, which only temporarily relieves symptoms and cannot cure the condition. It has the advantages of holistic conditioning and fewer side effects, providing a safe, effective, and comprehensive treatment plan for tinnitus patients, and has high clinical application value and promotional significance.

The present invention relates to the technical field of traditional Chinese medicine, and discloses a prescription for treating chronic atrophic gastritis, which is composed of the following raw materials: Fructus Aurantii 9-15 g, Magnolia officinalis 9-15 g, dried ginger 6-9 g, Codonopsis pilosula 15-30 g, Poria cocos 15-30 g, Pinellia ternata 9-15 g, Panax notoginseng powder 6-9 g, Hedyotis diffusa 15-30 g, Scutellaria barbata 9-15 g, and is composed of the following raw materials: Fructus Aurantii 12 g, dried ginger 6 g, Magnolia officinalis 12 g, Codonopsis pilosula 20 g, Poria cocos 15 g, Pinellia ternata preparata 12 g, Panax notoginseng powder 9 g, Scutellaria barbata 12 g, Hedyotis diffusa 15 g. The total effective rate of the treatment group (95.00%) was higher than that of the control group (72.50%) (P < 0.05); the levels of TNF-α, IL-2, and IL-6 in both groups after treatment were lower than those before treatment in the same group (P < 0.05); the levels of TNF-α, IL-2, and IL-6 in the treatment group after treatment were lower than those in the control group (P < 0.05).

The invention relates to the technical field of traditional Chinese medicine preparations, and discloses a traditional Chinese medicine composition for treating hepatocellular carcinoma and application thereof, and the traditional Chinese medicine composition comprises the following components in parts by mass: 8-12 parts of ginseng, 13-17 parts of astragalus membranaceus, 8-12 parts of angelica sinensis, 8-12 parts of rhizoma polygonati, 8-12 parts of curcuma zedoary, 18-22 parts of oldenlandia diffusa, 8-12 parts of edible tulip, 3-6 parts of liquorice, 10-15 parts of sculellaria barbata and 5-10 parts of ganoderma lucidum spore powder. In the composition, the ginseng, the astragalus membranaceus and other medicines can enhance the immunity of the organism and protect hepatocytes, the curcuma zedoary, the oldenlandia diffusa and other medicines can directly inhibit tumor growth, and the curcuma zedoary and the oldenlandia diffusa and other medicines cooperate with each other, so that the composition not only improves the physique of a patient, but also plays an anti-tumor role, and accords with the pathogenesis characteristics of deficiency of vital qi and accumulation of pathogenic toxin of liver cancer.

The invention relates to an improved compound cocklebur fruit traditional Chinese medicine composition for treating allergic rhinitis, which is prepared from cocklebur fruit, folium mori, rhizoma phragmitis, platycodon grandiflorum, liquorice, rhizoma atractylodis, rhizoma zingiberis, radix sophorae flavescentis, rabdosia rubescens and cortex mori radicis according to a specific weight part ratio. The improved compound traditional Chinese medicine composition with a new prescription can effectively inhibit the key biological sites of the occurrence and development of rhinitis and improve the symptoms of rhinitis, and compared with the original compound fructus xanthii prescription, the improved compound traditional Chinese medicine composition has higher treatment efficiency and wider applicability to most people.

The invention discloses a formula of a soaking solution for manual repairing and mounting of ancient calligraphy and paintings, and belongs to the technical field of protection and repairing of the ancient calligraphy and paintings. The soaking solution is prepared from the following raw materials in parts by weight: 1 part of spica prunellae, 1 to 4 parts of semen cassiae torae, 1 to 4 parts of fructus gleditsiae, 1 part of polygala tenuifolia, 1 part of periostracum cicadae, 1 to 4 parts of radix dipsaci, 1 part of sculellaria barbata, 1 part of rhizoma alismatis, 1 part of oyster, 1 part of bryozoatum, 0.5 part of liquorice root and a proper amount of root-free water. The soak solution formula for manual repairing and mounting of the ancient calligraphy and painting has the beneficial effects that the protection and repairing effects of the ancient calligraphy and painting can be remarkably improved. The formula has excellent decontamination and ink fixing performance, can effectively enhance the tensile strength and folding strength of paper, and meanwhile prevents the ink falling phenomenon of calligraphy and painting in the repairing process.

The invention discloses an anti-breast cancer traditional Chinese medicine compound preparation as well as a preparation method and application thereof. The anti-breast cancer traditional Chinese medicine compound preparation is prepared from the following raw material medicines in parts by weight: 25-35 parts of ganoderma lucidum spore powder, 10-20 parts of edible tulip, 10-20 parts of sculellaria barbata, 20-30 parts of oldenlandia diffusa, 8-12 parts of detoxified nidus vespae, 20-30 parts of selfheal, 10-20 parts of akebia fruit and 15-25 parts of uniflower swisscentaury root. Ganoderma lucidum spore powder is used as a monarch drug instead of a tonic drug, so that the risk of excessive activation of immunity is avoided; the retention rate of triterpenes is greater than or equal to 95% and the yield of polysaccharides is greater than or equal to 15% through a segmented extraction Establishing a nidus vespae detoxification process and a nidus vespae oil limit standard; by removing tumor-promoting risk medicinal materials, introducing active synergistic components and innovating a toxicity control process, the anti-tumor activity and medication safety are remarkably improved, and the composition is suitable for adjuvant therapy of breast cancer.

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine plaster formula targeting tumor acupoints and application of the traditional Chinese medicine plaster formula, the traditional Chinese medicine plaster formula is composed of 24 traditional Chinese medicines such as musk, oldenlandia diffusa and sculellaria barbata, the scheme deeply integrates traditional Chinese medicine transdermal absorption and meridian targeting tropism mechanisms, and the limitation that traditional external treatment neglects overall differentiation is broken through. According to the preparation process, through segmented treatment and low-temperature reaction, the sensitization risk of minium is remarkably reduced, the anti-tumor curative effect can be synergistically enhanced, cancer pain can be relieved, malignant effusion can be controlled, particularly, the dosage of western medicines can be reduced and toxic and side effects can be reduced when the medicine is combined with radiotherapy and chemotherapy, and a safe and effective adjuvant therapy means is provided for tumor patients.

The invention provides a traditional Chinese medicine composition with antibacterial and antiviral effects and application, and relates to the technical field of traditional Chinese medicine pharmacy, the traditional Chinese medicine composition is composed of fourteen traditional Chinese medicines: artemisia capillaris, radix clematidis, glabrous sarcandra herb, yam rhizome, shrubalthea flower, spina gleditsiae, ramuli euonymi, pogostemon cablin, oldenlandia diffusa, sculellaria barbata, eclipta, fennel, fingered citron and tribulus terrestris; in-vitro experiments show that the traditional Chinese medicine composition has broad-spectrum antiviral activity, and the inhibition rate of the traditional Chinese medicine composition to various viruses reaches 60% or above; in-vivo experiments prove that the traditional Chinese medicine composition disclosed by the invention has remarkable antibacterial activity: the serum inflammatory factor level of a rat with chronic pelvic inflammation caused by bacteria can be effectively regulated and controlled, and the uterus swelling rate is reduced; the traditional Chinese medicine composition can obviously relieve fungal infection mouse skin injury, reduces PASI score, slows down pathological process by regulating and controlling serum inflammatory factor level, and provides a safe and effective scheme for treatment of infectious diseases.

This invention relates to the field of traditional Chinese medicine composition technology, and in particular to a traditional Chinese medicine composition for treating lung cancer and its preparation method, comprising composition one, composition two, and composition three; composition one, by weight parts, comprises: Astragalus membranaceus 20-45 parts, Polygonatum odoratum 15-30 parts, Ophiopogon japonicus 8-18 parts, Coix lacryma-jobi 20-45 parts, Phragmites communis 20-45 parts, and Glycyrrhiza uralensis 3-6 parts; composition two, by weight parts, comprises: Clematis armandii 9-15 parts, Actinidia chinensis root 15-30 parts, Scutellaria barbata 10-22 parts, Pinellia ternata 6-13 parts, Fritillaria thunbergii 6-13 parts, and Citrus reticulata peel 6-13 parts; composition three, by weight parts, comprises: Buthus martensii 3-8 parts. The traditional Chinese medicine composition prepared by this invention has the effects of invigorating qi and nourishing yin, clearing heat and detoxifying, resolving phlegm and dissipating nodules, and promoting blood circulation and unblocking collaterals. It overcomes the technical problems of existing anti-lung cancer chemotherapy drugs having large toxic side effects and easily developing drug resistance, as well as the limited anti-lung cancer effects of existing single or simple compound traditional Chinese medicines, and the lack of optimization in compatibility and process.

This invention discloses a medicinal ointment for treating Qi deficiency and blood stasis syndrome and its preparation method. The raw materials of the medicinal ointment include: ginseng, atractylodes macrocephala, astragalus membranaceus, rehmannia glutinosa, dandelion, chuanxiong rhizome, costus root, turmeric, salvia miltiorrhiza, peucedanum praeruptorum, apricot kernel, sparganium rhizome, scutellaria barbata, oldenlandia diffusa, licorice, and gelatinous medicinal materials. The preparation method involves decocting the medicinal formula and then adding gelatinous materials to form the ointment. This invention improves the loss of appetite and fatigue in mice with non-small cell lung cancer syndrome caused by Qi deficiency and blood stasis syndrome by modifying the traditional Chinese medicine formula and preparing it as an ointment. It reduces whole blood and plasma viscosity by tonifying Qi, activating blood circulation, and removing blood stasis, thus promoting blood flow without damaging hepatocytes and reducing the toxic side effects of the formula on the liver. Furthermore, the ointment preparation makes it convenient for patients to carry and take.

The traditional Chinese medicine bag is prepared from the following plant medicinal materials in percentage by mass: dandelion, lycopodium clavatum, garden balsam stem, honeysuckle, patrinia, motherwort, tuber fleeceflower stem, hypericum japonicum, sculellaria barbata and the like. The traditional Chinese medicine composition comprises 10% of dandelion, 8% of lycopodium clavatum, 25% of garden balsam stem, 5% of honeysuckle, 8% of patrinia, 5% of motherwort, 5% of tuber fleeceflower stem, 5% of hypericum japonicum, 10% of sculellaria barbata, 4% of mulberry leaf, 5% of moghania affinis, 5% of rhodobryum giganteum and 5% of boschniakia rossica, and when the traditional Chinese medicine composition is used, the sustained release of the drug effect is enhanced through a special extraction process. Therefore, a three-layer structure adopting a sealing bag design inside supports replacement of medicinal materials, an outer package can be cleaned and antibacterial, the problems of waste and inconvenience caused by disposable use of a traditional Chinese medicine bag are solved, and through layered release of the medicine effect, construction of a controlled-release medicine environment and design of reutilization, the medicine effect is improved. The defects of short drug effect duration, dependence on external factors and inconvenience in use in the prior art are systematically solved, and long-acting and stable meridian-dredging, antibacterial and anti-inflammatory effects are achieved.

The invention discloses a traditional Chinese medicine composition for treating thyroid cancer as well as a preparation method and application thereof, and relates to the technical field of traditional Chinese medicine formulas. The traditional Chinese medicine composition for treating thyroid cancer comprises aged black nightshade, marsdenia tenacissima, podophyllum, thunberg fritillary bulb, sculellaria barbata, radix bupleuri, fried gardenia, cortex moutan, angelica sinensis, ligusticum wallichii, poria cocos, radix curcumae, radix ranunculi ternati, radix semiaquilegiae, blackberry lily, wild buckwheat, rhizoma smilacis glabrae, rhizoma dioscoreae nipponicae, rhizoma cyperi, radix paeoniae alba, salvia chinensis, salvia miltiorrhiza, plantain herb, burdock and polygala tenuifolia. And the traditional Chinese medicine composition is safe and reliable.

The invention belongs to the technical field of traditional Chinese medicine preparation, and particularly relates to a medicine for treating cerebral arterial thrombosis, the medicine is prepared from the following raw materials in parts by weight: 10-15 parts of angelica sinensis, 6-10 parts of ligusticum wallichii, 10-15 parts of salvia miltiorrhiza, 6-10 parts of frankincense, 6-10 parts of myrrh, 3-6 parts of leech, 10-15 parts of centella asiatica and 10-15 parts of sculellaria barbata, experiments show that the medicine can effectively improve neurological functions; the cerebral infarction volume of the rat can be obviously reduced; in the aspect of brain tissue pathological damage, after the medicine is added for intervention, pathological changes such as nerve cell degeneration and necrosis occurring in a model group can be relieved to different degrees; under the condition of neuron apoptosis, the number of apoptotic cells of a model group is increased, and the medicine can reduce the number of apoptotic cells; in general, the medicine provided by the invention has a remarkable treatment effect on patients suffering from cerebral arterial thrombosis.

The invention discloses traditional Chinese medicine granules for treating liver cancer and a preparation method thereof, and relates to the technical field of traditional Chinese medicine formulas. The traditional Chinese medicine granules for treating liver cancer are prepared from aged black nightshade, marsdenia tenacissima, podophyllum, thunberg fritillary bulb, sculellaria barbata, oldenlandia diffusa, lucid ganoderma, phellinus igniarius, polygonum cuspidatum, sedum sarmentosum, lysimachia christinae hance, hypericum japonicum, dandelion, roasted turtle shell, astragalus membranaceus, ginger processed pinellia, scorpio and reed rhizome. The traditional Chinese medicine composition is composed of sargentgloryvine stem, patrinia heterophylla, codonopsis pilosula, Chinese yam, bighead atractylodes rhizome, fried endothelium corneum gigeriae galli, curcuma zedoary, radix curcumae, inula flower, achyranthes root, Chinese polyphaga, honeycomb, processed rhizoma cyperi, radix ophiopogonis, fig and silybum marianum, has the effects of detoxifying and improving symptoms, can finally reduce relapse, and is safe and reliable.

A method for preparing an anti-tumor traditional Chinese medicine compound formulation containing isoquercitrin. The specific preparation steps of the anti-tumor traditional Chinese medicine compound formulation containing isoquercitrin are as follows: 8-10 g of Taxus chinensis, 6-12 g of Paris polyphylla, 15-17 g of Solanum nigrum, 3-7 g of Taraxacum officinale, 5-10 g of Angelica sinensis, 12-14 g of Poria cocos, 13-15g of Astragalus membranaceus, 8-10g of Panax ginseng,13-15g of Ganoderma lucidum, 8-10g of Scutellaria barbata, 13-15g of Sophora flavescens, 14-16g of Rabdosia rubescens, 8-12g of Panax notoginseng, 15-17g of Scleromitrion diffusum, 16-17g of Lithospermum erythrorhizon, 8-12g of Morus alba, and 13-14g of Sophora japonica. The raw material formula of the present application incorporates Morus alba and Sophora japonica, and the Morus alba and Sophora japonica are rich in isoquercitrin and have antioxidant, anti-inflammatory and potential antitumor effects, thus significantly enhancing the efficacy of the traditional Chinese medicine compound formulation. Moreover, the preparation process of the formulation is simple. After the preparation of the formulation is completed, the concentration of the isoquercitrin content can be quantitatively determined by using high-performance liquid chromatography technology, and an acute toxicity test and a long-term toxicity test are performed to ensure the safety of the formulation.